Skip to main content

Table 2 The comparison of baseline characteristics between the CR and non-CR groups

From: Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study

Baseline characteristics   CR group Non-CR group p value
Number of cases N 13 13  
Age Median
(min–max)
53 (25–68) 23 (16–70) 0.09
Gender—male N (%) 4 7 0.234
Body weight, kg Median
(min–max)
47
(43.7–68.2)
55
(37.7–83.3)
0.48
Duration of disease, month Median
(min–max)
118
(12–159)
28
(6–130)
0.001
Extent of UC (Montreal classification)     0.42
  left side colitis (E2) N 4 6  
  pancolitis (E3) N 9 7  
Disease activity     
  pMayo score Median
(IQR)
6
(6–7)
7
(5–7)
0.76
  MES Median
(IQR)
2
(2–2)
2
(2–3)
0.03
Concomitant medication     
  5-aminosalicylic acid N (%) 12 10  
  Corticosteroid N (%) 4 3 0.658
  Immunosuppressant N (%) 5 8 0.239
  Anti-TNF-alpha agent N (%) 3 2 0.619
Biomarker at entry     
  FC (mg/kg) Median
(IQR)
15,669
(7280–20,017)
9496
(1073–14,015)
0.07
  WBC count Median
(IQR)
5980
(4760–6970)
7290
(5200–8250)
0.29
  CRP (mg/dL) Median
(IQR)
0.66
(0.1–4.56)
0.36
(0.1–1.26)
0.53